Why Infectious Aerosols Are More Dangerous Than Droplets
Read Part 1: Aerosols Are Infectious & More Dangerous Than Droplets
Infectious Aerosols: Small but Potent
Many COVID-19 precautions—plexiglass barriers, six-foot desk spacing, and reduced room occupancy—rely on an outdated assumption: that large respiratory droplets pose the greatest threat.
In reality, the most dangerous droplets are microscopic particles, particularly those measuring 2 μm to 3 μm.
Aerosols do more than hover in the air for hours and travel across rooms. They also carry significantly higher concentrations of infectious virus than large droplets.
“Humans produce infectious aerosols across a range of particle sizes, but pathogens predominate in small particles,” explains Kevin Fennelly, M.D., of the National Institutes of Health (NIH).
This principle applies directly to influenza, SARS-CoV-2, and other respiratory pathogens, notes William Lindsley, Ph.D., a biochemical engineer with the U.S. Centers for Disease Control and Prevention (CDC).
“You see a lot more virus in small aerosols,” Lindsley stated during an international conference on airborne transmission.
Why Particle Origin Matters
This high viral concentration stems from where aerosols originate: deep within the lungs. Research demonstrates that the viral load of SARS-CoV-2 is significantly higher in the lower respiratory tract than in the upper airways.
Because aerosols are microscopic, inhaled particles penetrate deep into alveolar lung tissue. Severe COVID-19 outcomes—such as pneumonia or acute respiratory distress syndrome—occur when the virus reaches the lower airways. Only fine aerosols can travel that far.
“If the virus penetrates deeper into the respiratory system, fewer particles are required to initiate infection, increasing disease severity,” reported aerosol scientist Linsey Marr, Ph.D.
Responding to skepticism surrounding airborne transmission, Dr. Fennelly adds: “There is no evidence supporting the concept that most respiratory infections spread primarily through large droplets. Small-particle aerosols are the rule, rather than the exception.”
NanoStrike™ Technology: Neutralizing Airborne Viruses
To combat airborne transmission effectively, indoor facilities cannot rely solely on physical distancing, hand hygiene, and surface cleaning. Standard distancing rules offer limited indoor protection because six-foot barriers do not stop floating aerosols from dispersing across a room.
Indoor environments require active, continuous air disinfection, such as NanoStrike technology from WellAir.
WellAir devices utilize an ultra-low-energy plasma field that inactivates airborne pathogens at the cellular level. Deployed across 65 countries, this technology protects critical healthcare spaces, including operating rooms, intensive care units, emergency departments, and surgical suites.
The Novaerus Defend 1050—cleared by the U.S. FDA as a 510(k) Class II medical device—is proven by independent laboratory testing to filter and deactivate viruses and bacteria continuously.
In independent testing, the Defend 1050 achieved a 99.99% reduction of MS2 bacteriophage (a recognized surrogate for SARS-CoV-2) in just 15 minutes. It demonstrates equal efficacy against influenza, Clostridium difficile, Aspergillus, and surrogates for Measles, Tuberculosis, and MRSA.
By rendering pathogens inactive, portable WellAir units recirculate clean, disinfected air without producing harmful byproducts. Unlike technologies that emit ozone or chemicals, NanoStrike devices operate safely 24/7 around vulnerable patients.
Beyond medical settings, WellAir systems protect commercial operations across retail, hospitality, and corporate office spaces—from hotel lobbies to tasting rooms at Jarvis Estate Winery.
Historical Lessons: From Measles to COVID-19
In 1982, a measles outbreak in a pediatric clinic infected three children who arrived over an hour after the infected patient had departed.
Rather than treating the case as an anomaly, public health researchers recognized that conventional assumptions about droplet transmission were flawed.
“Airborne transmission may occur more often than previously suspected,” epidemiologists concluded in the Journal of the American Medical Association.
With COVID-19 and other emerging pathogens, scientific consensus reached that same conclusion. Building managers and facility engineers must now upgrade indoor air mitigation to match modern transmission science.
Schedule a demo to learn more about WellAir air disinfection solutions.